Last reviewed · How we verify
No Treatment Added
No Treatment Added is a control arm representing standard care without an investigational therapeutic intervention.
At a glance
| Generic name | No Treatment Added |
|---|---|
| Also known as | Lyrica (r) |
| Sponsor | Azienda Ospedaliero-Universitaria di Modena |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
This is a comparator or control group designation used in clinical trials, not an active pharmaceutical agent. It represents the baseline standard of care or placebo against which an investigational drug's efficacy and safety are measured in a Phase 3 trial.
Approved indications
Common side effects
Key clinical trials
- Shared Decision-Making Decision Aid for Newly Diagnosed Breast Cancer : A Multi-Center Randomized Controlled Trial (NA)
- Impact of a Mindfulness Intervention on Infertile Women Undergoing Assisted Reproductive Technique Treatments (NA)
- IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation (NA)
- Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer (PHASE3)
- Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma (PHASE2)
- National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies
- Transcatheter Aortic Valve Replacement Versu Surgical Aortix Valve Replacement for Treating Elderly Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Prospective Randomized Study The VIVA Trial (NA)
- A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- No Treatment Added CI brief — competitive landscape report
- No Treatment Added updates RSS · CI watch RSS
- Azienda Ospedaliero-Universitaria di Modena portfolio CI